Multicenter Registration Study on Allergic Bronchopulmonary Aspergillosis

To understand the current diagnosis and treatment status of ABPA patients, observe their clinical characteristics, prognosis, and treatment outcomes, and identify the relevant factors for poor prognosis in patients.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Allergic Bronchopulmonary Aspergillosis Aspergillosis Aspergillosis, Allergic Bronchopulmonary Bacterial Infections and Mycoses Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Infections Lung Diseases Lung Diseases, Fungal Mycoses Pulmonary Aspergillosis Respiratory Hypersensitivity Respiratory Tract Diseases Respiratory Tract Infections

Age range

18 year–85 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Peking University Third Hospital

Beijing, Beijing Municipality, 100191, China

Location contact

CONTACT

[email protected]

15801601229

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Meeting the diagnosis of ABPA according to the ABPA diagnostic criteria specified by the ISHAM-ABPA working group in 2024

Exclusion criteria

ABPA patients who are not first diagnosed in the center

Treatment and study plan

Primary outcomes

Clinical classification and treatment response criteria for ABPA

Time frame: 1 year
- Acute ABPA
- Response
- Remission
- Treatment-dependent ABPA
- Advanced ABPA

Sponsors and collaborators

Lead sponsor

Peking University Third Hospital

Other

Collaborators

First Affiliated Hospital of Guangxi Medical University
Guangzhou Institute of Respiratory Disease
Nanfang Hospital, Southern Medical University
Peking Union Medical College Hospital
Qianfoshan Hospital
Ruijin Hospital
Second Affiliated Hospital of Xi'an Jiaotong University
Second Affiliated Hospital, School of Medicine, Zhejiang University
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
The First Affiliated Hospital of Shanxi Medical University
The First Affiliated Hospital with Nanjing Medical University
Tongji Hospital
West China Hospital
Xiangya Hospital of Central South University

Registry information

Official study title

A Multicenter Retrospective Cohort Study on Allergic Bronchopulmonary Aspergillosis

Important dates

Study start: 2024
Primary completion: 2025
Study completion: 2026
First posted: Oct 16, 2024
Registry last updated: Oct 16, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting